These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 8632303

  • 1. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
    Ehlert FJ, Oliff HS, Griffin MT.
    J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303
    [Abstract] [Full Text] [Related]

  • 2. Conversion of N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) to an aziridinium ion and its interaction with muscarinic receptors in various tissues.
    Thomas EA, Hsu HH, Griffin MT, Hunter AL, Luong T, Ehlert FJ.
    Mol Pharmacol; 1992 Apr; 41(4):718-26. PubMed ID: 1569923
    [Abstract] [Full Text] [Related]

  • 3. Kinetics of activation and in vivo muscarinic receptor binding of N-(2-bromoethyl)-4-piperidinyl diphenylacetate: an analog of 4-DAMP mustard.
    Griffin MT, Thomas EA, Ehlert FJ.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):301-5. PubMed ID: 8331565
    [Abstract] [Full Text] [Related]

  • 4. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J, Bacáková L, el-Fakahany EE, Tucek S.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [Abstract] [Full Text] [Related]

  • 5. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G, Waelbroeck M, Mash DC, Flynn DD.
    Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
    [Abstract] [Full Text] [Related]

  • 6. The interaction of 4-DAMP mustard with subtypes of the muscarinic receptor.
    Ehlert FJ.
    Life Sci; 1996 Dec; 58(22):1971-8. PubMed ID: 8637426
    [Abstract] [Full Text] [Related]

  • 7. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
    Flynn DD, Mash DC.
    Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
    [Abstract] [Full Text] [Related]

  • 8. Antagonist binding profiles of five cloned human muscarinic receptor subtypes.
    Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):727-33. PubMed ID: 1994002
    [Abstract] [Full Text] [Related]

  • 9. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM, Sherwin JD, Tidmarsh MD, Appadu BL, Lambert DG.
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [Abstract] [Full Text] [Related]

  • 10. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 11. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
    Buckley NJ, Bonner TI, Buckley CM, Brann MR.
    Mol Pharmacol; 1989 Apr; 35(4):469-76. PubMed ID: 2704370
    [Abstract] [Full Text] [Related]

  • 12. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S, Buckley NJ, Roberts FF.
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [Abstract] [Full Text] [Related]

  • 13. Differential coupling of m1, m2 and m3 muscarinic receptor subtypes to inositol 1,4,5-trisphosphate and adenosine 3',5'-cyclic monophosphate accumulation in Chinese hamster ovary cells.
    Burford NT, Tobin AB, Nahorski SR.
    J Pharmacol Exp Ther; 1995 Jul; 274(1):134-42. PubMed ID: 7616390
    [Abstract] [Full Text] [Related]

  • 14. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.
    Lazareno S, Dolezal V, Popham A, Birdsall NJ.
    Mol Pharmacol; 2004 Jan; 65(1):257-66. PubMed ID: 14722259
    [Abstract] [Full Text] [Related]

  • 15. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
    Ehlert FJ, Griffin MT, Glidden PF.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic characterization of muscarinic receptors of insect brains.
    Abdallah EA, Eldefrawi ME, Eldefrawi AT.
    Arch Insect Biochem Physiol; 1991 Dec; 17(2-3):107-18. PubMed ID: 1802028
    [Abstract] [Full Text] [Related]

  • 17. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC, Maullu C, Onali P.
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [Abstract] [Full Text] [Related]

  • 18. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.
    Gharagozloo P, Lazareno S, Popham A, Birdsall NJ.
    J Med Chem; 1999 Feb 11; 42(3):438-45. PubMed ID: 9986715
    [Abstract] [Full Text] [Related]

  • 19. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
    Wang SZ, el-Fakahany EE.
    J Pharmacol Exp Ther; 1993 Jul 11; 266(1):237-43. PubMed ID: 7687290
    [Abstract] [Full Text] [Related]

  • 20. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes.
    Lee NH, el-Fakahany EE.
    J Pharmacol Exp Ther; 1991 Feb 11; 256(2):468-79. PubMed ID: 1993991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.